These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28468529)

  • 1. Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations.
    Al-Mahayri ZN; Patrinos GP; Ali BR
    Pharmacogenomics; 2017 May; 18(7):687-699. PubMed ID: 28468529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment.
    Pavlovic S; Kotur N; Stankovic B; Zukic B; Gasic V; Dokmanovic L
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30832275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of pediatric acute lymphoblastic leukemia.
    Meeker ND; Yang JJ; Schiffman JD
    Expert Opin Pharmacother; 2010 Jul; 11(10):1621-32. PubMed ID: 20429672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
    Jakab Z; Balogh E; Karászi E; Kappelmayer J; Kiss C; Oláh E
    Med Pediatr Oncol; 2002 Jul; 39(1):63-5. PubMed ID: 12116086
    [No Abstract]   [Full Text] [Related]  

  • 5. Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD).
    Hui L; Wiernik PH
    Am J Hematol; 1996 Jul; 52(3):184-8. PubMed ID: 8756084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics in acute lymphoblastic leukemia.
    Lee SHR; Yang JJ
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):229-236. PubMed ID: 29050696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
    Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
    Bancillon A
    Arch Fr Pediatr; 1991 Oct; 48(8):593-4. PubMed ID: 1768205
    [No Abstract]   [Full Text] [Related]  

  • 9. [L-asparaginase-induced hyperlipidemia in a case of acute lymphoblastic leukemia].
    Konya H; Tamura S; Miyazaki E; Inoue N; Okamoto T; Takemoto Y; Kohsaki M; Kanemaru A; Kakishita E
    Rinsho Ketsueki; 1991 Mar; 32(3):250-4. PubMed ID: 2041167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
    Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].
    Fu RY; Liao QK; Jia CS
    Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):515-9. PubMed ID: 14746678
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacogenomics of acute lymphoblastic leukemia].
    Ansari M; St-Onge G; Krajinovic M
    Med Sci (Paris); 2007 Nov; 23(11):961-7. PubMed ID: 18021708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
    Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia.
    Wu C; Li W
    Crit Rev Oncol Hematol; 2018 Jun; 126():100-111. PubMed ID: 29759551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of methotrexate in children with acute lymphoblastic leukemia].
    Lares-Asseff I; Paredes R; Taboada C; Cravioto J; Velázquez M; Roldán RM; Faisal AG
    Bol Med Hosp Infant Mex; 1988 Oct; 45(10):671-80. PubMed ID: 3264171
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM
    Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.